Post-stroke Neural Plasticity With Atomoxetine

NCT02788357 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Atomoxetine Hydrochloride
Placebos

Interventions

DRUG: Atomoxetine
DRUG: Placebo

Sponsor

Lumy Sawaki